HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Arnon Nagler Selected Research
Arnon Nagler Research Topics
Disease
189
Leukemia
10/2022 - 01/2002
154
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
10/2022 - 01/2002
94
Neoplasms (Cancer)
01/2022 - 01/2002
82
Graft vs Host Disease (Graft-Versus-Host Disease)
10/2022 - 12/2002
59
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
03/2022 - 01/2002
54
Multiple Myeloma
01/2022 - 12/2002
32
Hematologic Neoplasms (Hematological Malignancy)
01/2022 - 03/2002
24
BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2022 - 01/2002
24
Lymphoma (Lymphomas)
12/2021 - 08/2003
21
Infections
12/2021 - 12/2002
17
Myelodysplastic Syndromes (Myelodysplastic Syndrome)
11/2021 - 12/2007
17
Bronchiolitis Obliterans Syndrome
11/2021 - 08/2002
14
Pathologic Complete Response
10/2022 - 10/2004
13
B-Cell Lymphoma (Lymphoma, B Cell)
01/2022 - 11/2007
12
Non-Hodgkin Lymphoma (Lymphosarcoma)
11/2021 - 01/2002
10
Neoplasm Metastasis (Metastasis)
10/2018 - 12/2002
9
Philadelphia Chromosome
01/2021 - 04/2006
9
Fibrosis (Cirrhosis)
01/2013 - 07/2003
8
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2021 - 01/2008
8
Residual Neoplasm
12/2020 - 01/2004
8
Chromosome Aberrations (Chromosome Abnormalities)
01/2020 - 10/2007
7
Primary Myelofibrosis (Myelosclerosis)
11/2021 - 12/2009
7
Inflammation (Inflammations)
01/2021 - 08/2009
7
Melanoma (Melanoma, Malignant)
01/2020 - 03/2006
7
Hodgkin Disease (Hodgkin's Disease)
11/2018 - 06/2003
7
Disease Progression
06/2015 - 03/2007
6
Hematologic Diseases (Blood Diseases)
01/2021 - 01/2013
6
Blast Crisis (Blast Phase)
10/2019 - 01/2002
6
Neutropenia
10/2019 - 08/2003
5
Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2019 - 01/2012
5
Thrombocytopenia (Thrombopenia)
01/2018 - 06/2010
4
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
02/2019 - 01/2002
3
Polycythemia Vera
12/2022 - 12/2009
Drug/Important Bio-Agent (IBA)
49
Cyclophosphamide (Cytoxan)
FDA Link
Generic
10/2022 - 10/2013
28
fludarabine
IBA
01/2022 - 12/2002
27
Busulfan (Busulfex)
FDA Link
01/2022 - 01/2003
24
Antilymphocyte Serum (Anti-Thymocyte Globulin)
IBA
01/2022 - 12/2002
19
halofuginone
IBA
06/2015 - 05/2002
16
Chimeric Antigen Receptors
IBA
01/2022 - 09/2014
13
Bortezomib (Velcade)
FDA Link
12/2020 - 04/2006
11
Melphalan (Alkeran)
FDA Link
Generic
01/2022 - 12/2002
11
Tyrosine Kinase Inhibitors
IBA
01/2022 - 06/2010
11
Thiotepa (Triethylenethiophosphoramide)
FDA Link
Generic
01/2022 - 01/2016
11
heparanase
IBA
12/2021 - 01/2002
11
Granulocyte Colony-Stimulating Factor (G-CSF)
IBA
12/2021 - 01/2004
11
Proteins (Proteins, Gene)
FDA Link
02/2017 - 01/2002
11
Imatinib Mesylate (Gleevec)
FDA Link
05/2014 - 10/2004
10
treosulfan
IBA
01/2022 - 12/2007
10
Antibodies
IBA
01/2020 - 05/2002
10
Collagen
IBA
11/2012 - 05/2002
9
Cyclosporine (Ciclosporin)
FDA Link
Generic
01/2022 - 01/2003
9
Pharmaceutical Preparations
IBA
12/2019 - 09/2003
9
Ligands
IBA
01/2019 - 06/2005
8
Methotrexate (Mexate)
FDA Link
Generic
01/2022 - 01/2003
8
Antigens
IBA
01/2022 - 03/2003
7
HLA Antigens (Human Leukocyte Antigens)
IBA
01/2022 - 11/2008
6
Mycophenolic Acid (Cellcept)
FDA Link
Generic
01/2022 - 03/2016
6
Rituximab (Mabthera)
FDA Link
01/2018 - 08/2003
6
Azacitidine (5 Azacytidine)
FDA Link
04/2017 - 05/2010
6
Collagen Type I (Type I Collagen)
IBA
02/2007 - 07/2003
5
Lenalidomide (CC 5013)
FDA Link
01/2021 - 04/2008
5
Steroids
IBA
02/2020 - 12/2002
5
Globulins
IBA
02/2020 - 01/2003
5
tisagenlecleucel
IBA
01/2020 - 01/2019
5
Monoclonal Antibodies
IBA
01/2019 - 01/2003
5
1-dodecylpyridoxal (PLD)
IBA
07/2016 - 09/2007
5
liposomal doxorubicin (Doxil)
FDA Link
07/2016 - 09/2007
5
BKT140
IBA
05/2014 - 03/2011
4
Calcineurin Inhibitors
IBA
01/2021 - 03/2016
4
Dexamethasone (Maxidex)
FDA Link
Generic
12/2020 - 01/2012
4
Thomsen-Friedenreich antibodies
IBA
02/2020 - 01/2003
4
Sorafenib (BAY 43-9006)
FDA Link
03/2019 - 01/2018
4
RNA (Ribonucleic Acid)
IBA
01/2019 - 01/2002
4
Enzymes
IBA
10/2018 - 09/2008
4
Interleukin-15 (Interleukin 15)
IBA
04/2018 - 08/2003
4
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
06/2015 - 09/2004
4
Alkaloids
IBA
06/2015 - 01/2011
4
Cytokines
IBA
12/2014 - 04/2010
4
Thalidomide (Thalomid)
FDA Link
09/2014 - 11/2004
4
Interleukin-2 (IL2)
IBA
09/2013 - 05/2009
4
Transforming Growth Factor beta (TGF-beta)
IBA
01/2011 - 09/2008
4
Interleukin-12 (IL 12)
IBA
09/2004 - 03/2003
3
Alemtuzumab (Campath)
FDA Link
01/2022 - 06/2005
Therapy/Procedure
185
Transplantation
10/2022 - 08/2002
155
Stem Cell Transplantation
10/2022 - 01/2002
90
Therapeutics
12/2022 - 03/2002
82
Hematopoietic Stem Cell Transplantation
10/2022 - 01/2002
61
Cell Transplantation
10/2022 - 02/2013
45
Drug Therapy (Chemotherapy)
03/2022 - 01/2002
24
Immunotherapy
01/2020 - 01/2002
22
Bone Marrow Transplantation (Transplantation, Bone Marrow)
01/2022 - 08/2002
20
Haploidentical Transplantation
01/2022 - 04/2015
17
Homologous Transplantation
01/2020 - 01/2002
8
Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
10/2022 - 04/2004
5
Autologous Transplantation
01/2022 - 01/2010
5
Salvage Therapy
01/2020 - 03/2008
5
Cell- and Tissue-Based Therapy (Cell Therapy)
01/2013 - 03/2006
4
Hematopoietic Stem Cell Mobilization
09/2021 - 01/2014
4
Radiotherapy
01/2018 - 05/2005
3
Induction Chemotherapy
02/2022 - 01/2021